Your browser doesn't support javascript.
loading
Dabrafenib and Trametinib prolong coagulation through the inhibition of tissue factor in BRAFv600e mutated melanoma cells in vitro.
Scatena, Cristian; Franceschi, Sara; Franzini, Maria; Sanguinetti, Chiara; Romiti, Nadia; Caponi, Laura; Mandalà, Mario; Mazzanti, Chiara Maria; Naccarato, Antonio Giuseppe.
Afiliação
  • Scatena C; 1Division of Surgical Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 57, 56126 Pisa, Italy.
  • Franceschi S; Fondazione Pisana per la Scienza, Pisa, Italy.
  • Franzini M; 3Division of Clinical Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Sanguinetti C; 3Division of Clinical Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Romiti N; 3Division of Clinical Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Caponi L; 3Division of Clinical Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Mandalà M; Unit of Medical Oncology, Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy.
  • Mazzanti CM; Fondazione Pisana per la Scienza, Pisa, Italy.
  • Naccarato AG; 1Division of Surgical Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 57, 56126 Pisa, Italy.
Cancer Cell Int ; 19: 223, 2019.
Article em En | MEDLINE | ID: mdl-31467489

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article